News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
167,408 Results
Type
Article (31738)
Company Profile (12)
Press Release (135658)
Section
Business (51863)
Career Advice (361)
Deals (3203)
Drug Delivery (7)
Drug Development (23748)
Employer Resources (32)
FDA (3296)
Job Trends (3151)
News (80094)
Policy (4131)
Tag
Academia (2387)
Alliances (10739)
Alzheimer's disease (461)
Approvals (3286)
Artificial intelligence (26)
Bankruptcy (18)
Best Places to Work (2628)
Breast cancer (30)
Cancer (243)
Cardiovascular disease (19)
Career advice (333)
Cell therapy (46)
Clinical research (17908)
Collaboration (71)
COVID-19 (1154)
C-suite (48)
Cystic fibrosis (16)
Data (269)
Diabetes (21)
Diagnostics (1592)
Earnings (6016)
Employer resources (29)
Events (16926)
Executive appointments (166)
FDA (3373)
Funding (74)
Gene therapy (37)
GLP-1 (113)
Government (927)
Healthcare (5013)
Infectious disease (1168)
Inflammatory bowel disease (30)
Interviews (40)
IPO (1440)
Job creations (573)
Job search strategy (312)
Layoffs (29)
Legal (671)
Liver cancer (17)
Lung cancer (37)
Manufacturing (17)
Medical device (2981)
Medtech (2982)
Mergers & acquisitions (1773)
Metabolic disorders (64)
Neuroscience (515)
NextGen Class of 2024 (1786)
Non-profit (1687)
Northern California (322)
Obesity (30)
Opinion (25)
Parkinson's disease (17)
Patents (16)
People (31549)
Phase I (5686)
Phase II (8217)
Phase III (5430)
Pipeline (45)
Postmarket research (955)
Preclinical (2983)
Press Release (25)
Radiopharmaceuticals (63)
Rare diseases (37)
Real estate (1265)
Regulatory (2783)
Research institute (1340)
Resumes & cover letters (23)
Southern California (239)
Startups (1098)
United States (2427)
Vaccines (170)
Weight loss (17)
Date
Today (29)
Last 7 days (174)
Last 30 days (647)
Last 365 days (7735)
2024 (6331)
2023 (9209)
2022 (11449)
2021 (13186)
2020 (12723)
2019 (12092)
2018 (8974)
2017 (8673)
2016 (8863)
2015 (10189)
2014 (7783)
2013 (7565)
2012 (7523)
2011 (7533)
2010 (6755)
Location
Africa (260)
Arizona (34)
Asia (10192)
Australia (2562)
California (626)
Canada (232)
China (49)
Colorado (32)
Connecticut (28)
Europe (26964)
Florida (75)
Georgia (21)
Illinois (85)
Indiana (35)
Maryland (70)
Massachusetts (378)
Michigan (17)
Minnesota (41)
New Jersey (159)
New York (193)
North Carolina (191)
Northern California (322)
Ohio (45)
Pennsylvania (136)
South America (288)
Southern California (239)
Texas (85)
Washington State (70)
167,408 Results for "fudan university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Ascletis Announces Dosing of the First Patient in Phase III Clinical Trial of ASC40 (Denifanstat) for Treatment of Acne
Ascletis Pharma Inc. announces dosing of the first patient in Phase III clinical trial of ASC40 for treatment of moderate to severe acne vulgaris at Huashan Hospital, Fudan University.
January 24, 2024
·
2 min read
Genetown
SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical Update Presented at ASCO 2024
Corbus Pharmaceuticals Holdings, Inc., announced , that the Poster [#296] Clinical Update Related to the First-In-Human Trial of SYS6002, A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate, has been presented at American Society of Clinical Oncology Annual Conference by Dr. Jian Zhang, Chief Physician, Deputy Director of Administration, Clinical director of Phase 1 Centre, Fudan University Shanghai Cancer Center.
June 1, 2024
·
7 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Everest Medicines Announces Commercial Launch and First Prescription for XERAVA® in China
Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”) announced today XERAVA® (eravacycline) has been successfully launched in China with its first prescription issued at Huashan Hospital affiliated to Fudan University.
July 26, 2023
·
5 min read
Bio NC
Pfizer invests $4.9M in McMaster University study to help improve care for multiple myeloma patients in Canada
Pfizer is proud to announce that it is supporting a McMaster University-led study, through the Ontario Clinical Oncology Group, that aims to improve care for Canadians living with multiple myeloma.
June 3, 2024
·
5 min read
Press Releases
HELP Therapeutics announces FDA clearance of IND application for universal iPSC-derived HiCM-188 cell therapy for the treatment of end-stage heart failure
October 22, 2024
·
4 min read
Biotech Beach
Voycare Welcomes Fudan University’s Xuan Zhou to Board of Directors
North America Frac Sand, Inc. dba Voycare, a telemedicine service provider and Chinese language digital health platform exclusively dedicated to women’s health, is pleased to welcome Xuan Zhou of Fudan University to its Board of Directors.
August 27, 2020
·
4 min read
BioMidwest
University Cancer & Blood Center and University Health Alliance open High-Risk GI Clinic to address community needs
University Cancer & Blood Center, a leading oncology and hematology practice for Northeast Georgia, and University Health Alliance, a multi-disciplinary practice focusing on prevention and coordinated care, announce the opening of their High-Risk GI Clinic.
April 10, 2024
·
3 min read
BioMidwest
University of Cincinnati Cancer Center Launches Nation’s Most Comprehensive Blood Cancer Healing Center
The University of Cincinnati Cancer Center inaugurated its state-of-the-art Blood Cancer Healing Center, revolutionizing blood cancer care in the United States.
June 24, 2024
·
4 min read
1 of 16,741
Next